The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

While the initial purchase price was $600 million, the final amount could reach approximately $1.7 billion if certain milestones are met. V-Wave's Ventura Interatrial Shunt System for HFrEF has gained considerable interest in recent years, and Johnson & Johnson was an early investor in the technology back in 2016.

The ruling "gives insurers significant leverage to demand confiscatory discounts from out-of-network providers," the AMA, American Hospital Association and others contend. 

University Hospital Nantes in France will replace existing equipment with 9 new CT scanners and 6 MRI machines, among other upgrades in the 12-year contract. 

CMS is now accepting public comments on this topic until Nov. 2. A final decision is expected by July 2025.

The agency has received an increasing number of complaints from patients enrolled in a low-value health plan without their knowledge. If finalized, a new rule would empower CMS to ban brokers from the ACA marketplace. 

Early data suggest the drug, an oral lipoprotein (a) disruptor, could make a significant impact on patient care. AstraZeneca will pay $100 million upfront, with much more to follow if certain milestones are met. 

The new report could go on to help guide decisions made by CMS and hospital leadership teams for years to come.